NYU Langone Health (131) — New York, New York

NYU Langone Health (131) is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Langone Health (131) has participated in 1 clinical trials.

Therapeutic areas: Solid Tumor, Adult.

Sponsors: Immune-Onc Therapeutics.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Health (131)?

NYU Langone Health (131) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Health (131) conducted?

NYU Langone Health (131) has 1 clinical trials on record. Their work covers Solid Tumor, Adult.

Is NYU Langone Health (131) accredited by Crixeo Health?

NYU Langone Health (131) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Health (131)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.